Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease

References

• Aresu L, Benali S, Garbisa S, et al. (2011). Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition. Histol Histopathol 26:307–13
   PubMed Web of Science ®Google Scholar
• Chang HR, Yang SF, Li ML, et al. (2006). Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease. Clin Chim Acta 366:243–8
   PubMed Web of Science ®Google Scholar
• Chen J, Chen JK, Conway EM, Harris RC. (2013). Survivin mediates renal proximal tubule recovery from AKI. JASN 24:2023–33
   Web of Science ®Google Scholar
• Cheng S, Lovett DH. (2003). Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial–mesenchymal transformation. Am J Pathol 162:1937–49
   PubMed Web of Science ®Google Scholar
• Decleves AE, Sharma K. (2014). Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nat Rev Nephrol 10:257–67
   PubMed Web of Science ®Google Scholar
• Eddy AA. (2005). Can renal fibrosis be reversed? Pediatr Nephrol 20:1369–75
   PubMed Web of Science ®Google Scholar
• Fragiadaki A, Mason RM. (2011). Epithelial–mesenchymal transition in renal fibrosis – evidence for and against. Int J Exp Path 92:143–50
   PubMed Web of Science ®Google Scholar
• Frisch SM, Schaller M, Cieply B. (2013). Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis. J Cell Sci 126:21–9
   PubMed Web of Science ®Google Scholar
• Gonzalez-Avila G, Iturria C, Vadillo-Ortega F, et al. (1998). Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology 66:196–204
   PubMed Web of Science ®Google Scholar
• Hirt-Minkowski P, Marti HP, Hönger G, et al. (2014). Correlation of serum and urinary matrix metalloproteinases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation. Transplant Immunol 30:1–6
   PubMed Web of Science ®Google Scholar
• Iimura O, Takahashi H, Yashiro T, et al. (2004). Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex. Clin Exp Nephrol 8:223–9
   PubMedGoogle Scholar
• Ku JH, Godoy G, Amiel GE, Lerner SP. (2012). Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review. BJU Int 110:630–6
   PubMed Web of Science ®Google Scholar
• Liu Y. (2010). New insights into epithelial–mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212–22
   PubMed Web of Science ®Google Scholar
• Loeffler I, Wolf G. (2014). Transforming growth factor-beta and the progression of renal disease. Nephrol Dial Transplant 29:i37–45
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez FJ, Lopez-Novoa JM. (2012). Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347:141–54
   PubMed Web of Science ®Google Scholar
• Lurbe E, Cifkova R, Cruickshank JK, et al. (2009). Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–42
   PubMed Web of Science ®Google Scholar
• Mandelia A, Bajpai M, Agarwala S, et al. (2013). The role of urinary TGFbeta1, TNFalpha, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 28:1991–2001
   PubMed Web of Science ®Google Scholar
• McKittrick IB, Bogaert Y, Nadeau K, et al. (2011). Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am J Physiol Renal Physiol 301:F1326–33
   PubMed Web of Science ®Google Scholar
• Mehrotra S, Languino LR, Raskett CM, et al. (2010). IAP regulation of metastasis. Cancer Cell 17:53–64
   PubMed Web of Science ®Google Scholar
• Musiał K, Zwolińska D. (2011). Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment. Cell Stress Chaperones 16:97–103
   PubMed Web of Science ®Google Scholar
• Musiał K, Zwolińska D. (2013). New markers of apoptosis in children on chronic dialysis. Apoptosis 18:77–84
   PubMed Web of Science ®Google Scholar
• Musiał K, Zwolińska D. (2014). Novel indicators of fibrosis-related complications in children with chronic kidney disease. Clin Chim Acta 430:15–19
   PubMed Web of Science ®Google Scholar
• Onder TT, Gupta PB, Mani SA, et al. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68:3645–54
   PubMed Web of Science ®Google Scholar
• Pawlak K, Myśliwiec M, Pawlak D. (2011). Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis. Clin Biochem 44:838–43
   PubMed Web of Science ®Google Scholar
• Prunotto M, Budd DC, Meier M, et al. (2012). From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD. Nephrol Dial Transplant 27:iii43–50
   PubMedGoogle Scholar
• Schwartz GJ, Muñoz A, Schneider MF, et al. (2009). New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–37
   PubMed Web of Science ®Google Scholar
• Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. (2012). Anoikis: an emerging hallmark in health and diseases. J Pathol 226:380–93
   PubMed Web of Science ®Google Scholar
• Tan TK, Zheng G, Hsu TT, et al. (2010). Macrophage matrix metalloproteinase-9 mediates epithelial–mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176:1256–70
   PubMed Web of Science ®Google Scholar
• Tang Y, Kesavan P, Nakada MT, Yan L. (2004). Tumor–stroma interaction: positive feedback regulation of extracellular matrix inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2:73–80
   PubMed Web of Science ®Google Scholar
• Vianna HR, Soares CM, Silveira KD, et al. (2013). Cytokines in CKD: potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol 28:463–9
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 92:827–39
   PubMed Web of Science ®Google Scholar
• Yoo ChB, Yun SM, Jo Ch, Koh YH. (2012). γ-Secretase-dependent cleavage of E-cadherin by staurosporine in breast cancer cells. Cell Commun Adhesion 19:11–16
   PubMed Web of Science ®Google Scholar